MVM Partners, LLC bought $1000K of MDxHealth SA (MDXH)
Executed Aug 13, disclosed Aug 17, 4 days later.
Over the 21 trading sessions from the disclosed entry session (Aug 17), the stock returned -5.7% (delay-adjusted); from the execution session (Aug 13), +53.3%. Derived: entry at the session's open, exit at the close 20 sessions later.
MVM Partners, LLC (Director) filed 1 Form 4 report as a reporting entity in the trailing twelve months (1 purchase, 0 sales), most often in FNA. Across 1 priced purchase filing, the average 21-session return was +53.3% from execution and -5.7% from disclosure (delay-adjusted; derived). The largest single filing was $1000K of MDXH (2,202,643 sh × $0.45, as filed), executed Aug 13.
Healthcare · MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and international…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→